Brazil Halts the Final Stage China Vaccine Trial, Claims Serious Adverse Reaction
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI